Hisakane, K., Seike, M., Sugano, T., Yoshikawa, A., Matsuda, K., Takano, N., . . . Gemma, A. (2021). Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells. Thorac Cancer.
Citación estilo ChicagoHisakane, Kakeru, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda, Natsuki Takano, Satoshi Takahashi, Rintaro Noro, y Akihiko Gemma. "Exosome‐derived MiR‐210 Involved in Resistance to Osimertinib and Epithelial–mesenchymal Transition in EGFR Mutant Non‐small Cell Lung Cancer Cells." Thorac Cancer 2021.
Cita MLAHisakane, Kakeru, et al. "Exosome‐derived MiR‐210 Involved in Resistance to Osimertinib and Epithelial–mesenchymal Transition in EGFR Mutant Non‐small Cell Lung Cancer Cells." Thorac Cancer 2021.